Patents by Inventor Mark A. Muhlhauser

Mark A. Muhlhauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6150396
    Abstract: This invention provides methods for the treatment or prevention of interstitial cystitis or urethral syndrome in a mammal which comprise administering to a mammal in need thereof an effective amount of duloxetine.
    Type: Grant
    Filed: September 8, 1998
    Date of Patent: November 21, 2000
    Assignee: Eli Lilly and Company
    Inventors: Smriti Iyengar, Mark A. Muhlhauser, Karl B. Thor
  • Patent number: 6025379
    Abstract: This invention provides methods for the treatment or prevention of interstitial cystitis or urethral syndrome in a mammal which comprise administering to a mammal in need thereof an effective amount of a substituted benzimidazole, or a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: February 15, 2000
    Assignee: Eli Lilly and Company
    Inventors: Smriti Iyengar, Mark A. Muhlhauser, Karl B. Thor
  • Patent number: 6017930
    Abstract: This invention provides methods for the treatment or prevention of interstitial cystitis or urethral syndrome in a mammal which comprise administering to a mammal in need thereof an effective amount of a compound of formula (I), where R.sup.1 and R.sup.2 are independently selected from the group consisting of hydrogen, methyl, methoxy, chloro, and trifluoromethyl, with the proviso that no more than one of R.sup.1 and R.sup.2 can be hydrogen; and Y is (1), (2), (3), (4), (5), (6), N--R.sup.a, or CH--NR.sup.b R.sup.c, where R.sup.a, R.sup.b, and R.sup.c are independently selected from the group consisting of hydrogen and C.sub.1 -C.sub.6 alkyl; or a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: January 25, 2000
    Assignee: Eli Lilly and Company
    Inventors: Smriti Iyengar, Mark A. Muhlhauser, Karl B. Thor
  • Patent number: 5712287
    Abstract: The present invention relates to a novel method for treating a mammal suffering from urinary bladder dysfunctions.
    Type: Grant
    Filed: October 3, 1996
    Date of Patent: January 27, 1998
    Inventors: Mark A. Muhlhauser, Harlan E. Shannon, Karl B. Thor
  • Patent number: 5712271
    Abstract: The present invention relates to a novel method for treating a mammal suffering from urinary bladder dysfunctions.
    Type: Grant
    Filed: October 3, 1996
    Date of Patent: January 27, 1998
    Inventors: Mark A. Muhlhauser, Harlan E. Shannon, Karl B. Thor
  • Patent number: 5710151
    Abstract: The present invention relates to a novel method for treating a mammal suffering from urinary bladder dysfunctions.
    Type: Grant
    Filed: October 3, 1996
    Date of Patent: January 20, 1998
    Inventors: Mark A. Muhlhauser, Harlan E. Shannon, Karl B. Thor
  • Patent number: 5612351
    Abstract: The present invention relates to a novel method for treating a mammal suffering from urinary bladder dysfunctions.
    Type: Grant
    Filed: November 8, 1994
    Date of Patent: March 18, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Mark A. Muhlhauser, Harlan E. Shannon, Karl B. Thor
  • Patent number: 5565475
    Abstract: The present invention relates to a novel method for treating a mammal suffering from urinary bladder dysfunctions.
    Type: Grant
    Filed: November 8, 1994
    Date of Patent: October 15, 1996
    Inventors: Mark A. Muhlhauser, Harlan E. Shannon, Karl B. Thor